Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

911 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification.
Fukumoto W, Okamura S, Tamai M, Arima J, Kawahara I, Fukuda I, Mitsuke A, Sakaguchi T, Sugita S, Matsushita R, Tatarano S, Yamada Y, Nakagawa M, Enokida H, Yoshino H. Fukumoto W, et al. Among authors: tamai m. BMC Cancer. 2024 Oct 29;24(1):1333. doi: 10.1186/s12885-024-13109-5. BMC Cancer. 2024. PMID: 39472827 Free PMC article.
Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.
Yoshino H, Yokoyama S, Tamai M, Okamura S, Iizasa S, Sakaguchi T, Osako Y, Inoguchi S, Matsushita R, Yamada Y, Nakagawa M, Tatarano S, Tanimoto A, Enokida H. Yoshino H, et al. Among authors: tamai m. FEBS Open Bio. 2023 Jun;13(6):1056-1066. doi: 10.1002/2211-5463.13616. Epub 2023 Apr 29. FEBS Open Bio. 2023. PMID: 37079001 Free PMC article.
Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma.
Fukumoto W, Yoshino H, Horike SI, Kawakami I, Tamai M, Arima J, Kawahara I, Mitsuke A, Sakaguchi T, Inoguchi S, Meguro-Horike M, Tatarano S, Enokida H. Fukumoto W, et al. Among authors: tamai m. Cancer Sci. 2023 Oct;114(10):3946-3956. doi: 10.1111/cas.15914. Epub 2023 Aug 6. Cancer Sci. 2023. PMID: 37545017 Free PMC article.
Altered genomic methylation promotes Staphylococcus aureus persistence in hospital environment.
Yamazaki Y, Ito T, Nakagawa S, Sugihira T, Kurita-Tachibana C, Villaruz AE, Ishiguro K, Salcman B, Li S, Takada S, Inohara N, Kusuya Y, Shibata A, Tamai M, Aoyama R, Inoue K, Murata S, Matsushita K, Miyabe A, Taniguchi T, Igari H, Ishiwada N, Taniguchi M, Nakada TA, Matsue H, Fujimoto M, Hishiki H, Osone Y, Hamada H, Shimojo N, Suzuki T, Otto M, Núñez G, Takahashi H, Takaya A, Nakamura Y. Yamazaki Y, et al. Among authors: tamai m. Nat Commun. 2024 Nov 7;15(1):9619. doi: 10.1038/s41467-024-54033-3. Nat Commun. 2024. PMID: 39511195 Free PMC article.
Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster models.
Matthews MM, Kim TG, Kim KY, Meshcheryakov V, Iha HA, Tamai M, Sasaki D, Laurino P, Toledo-Patiño S, Collins M, Hsieh TY, Shibata S, Shibata N, Obata F, Fujii J, Ito T, Ito H, Ishikawa H, Wolf M. Matthews MM, et al. Among authors: tamai m. Sci Rep. 2024 Oct 26;14(1):25528. doi: 10.1038/s41598-024-76377-y. Sci Rep. 2024. PMID: 39462119 Free PMC article.
JunB is required for CD8+ T cell responses to acute infections.
Sarkar S, Taira N, Hsieh TH, Chien HC, Hirota M, Koizumi SI, Sasaki D, Tamai M, Seto Y, Miyagi M, Ishikawa H. Sarkar S, et al. Among authors: tamai m. Int Immunol. 2024 Oct 19:dxae063. doi: 10.1093/intimm/dxae063. Online ahead of print. Int Immunol. 2024. PMID: 39425978
911 results